초록 ▼

A coprecipitant and a nucleic-acid extraction method using the coprecipitant are provided. The coprecipitant has affinity to the nucleic acids, no competitive inhibition to the reverse transcription and no inhibition to the PCR reaction in case of extracting a very small amount of nucleic acids by a

A coprecipitant and a nucleic-acid extraction method using the coprecipitant are provided. The coprecipitant has affinity to the nucleic acids, no competitive inhibition to the reverse transcription and no inhibition to the PCR reaction in case of extracting a very small amount of nucleic acids by alcoholic precipitation using isopropyl alcohol or ethanol. Further, the coprecipitant can precipitate with the nucleic acids as a visible white or blue precipitate, thereby to suppress technical errors and enhance the extraction efficiency.A coprecipitant which acts in a process of extracting the nucleic acids by centrifugal separation from biological materials and/or test samples in the same manner as nucleic acids and has ability for precipitating as a visible white or blue precipitate when being separating and concentrating it by alcohol.

대표청구항 ▼

1. A method for enhancing the precipitation of nucleic acids from a biological sample, comprising the steps of:a) adding at least one coprecipitant which precipitates together with nucleic acids as a visible white or blue precipitate when separating and concentrating the nucleic acids by alcohol in

1. A method for enhancing the precipitation of nucleic acids from a biological sample, comprising the steps of:a) adding at least one coprecipitant which precipitates together with nucleic acids as a visible white or blue precipitate when separating and concentrating the nucleic acids by alcohol in a process of extracting with nucleic acids as a visible blue precipitate when separating and concentrating the nucleic acids by alcohol in a process of extracting the nucleic acids, at any of steps b-g;b) pretreating for lysing nucleic acids from biological sample;c) adding an aqueous liquid and a non-hydrophilic organic liquid having a high specific gravity and containing a thixotropic thickening agent to the pretreated biological sample;d) mixing the materials of c);e) centrifugal separation thereof;f) separating the upper phase containing nucleic acids by forming a non-flowable agglutinated phase i n a boundary interface between the upper and lower phases;g) blending the aqueous liquid containing nucleic acids by adding alcohol thereto; andh) separating and concentrating the nucleic acids together with said coprecipitant by centrifugal separation, such that a visible white or blue precipitate results. 2. The method of claim 1, wherein the coprecipitant is a composition selected from the group consisting of a long chain glucose bonded polysaccharide and a pigment-modified long chain glucose bonded polysaccharide. 3. The method of claim 1, wherein the coprecipitant is a composition comprising one or more kinds of starch selected from the group consisting of soluble starch, corn starch, potato starch, potato soluble starch, wheat starch, starch azure, corn amylopectin, potato amylopectin, amylopectin anthranilate, amylopectin azure, insoluble corn amylopectin, soluble potato amylopectin, corn amylose, potato amylose, and amylose azure. 4. A method according to claim 3, wherein said at least one coprecipitant is selected from the group consisting of starch azure, amylopectin azure and amylose azure, and said precipitate in step (h), is blue. 5. The method of claim 1, wherein the alcohol is isopropyl or ethanol. 6. The method of claim 1, wherein the nucleic acids are HCV-RNA. 7. The method of claim 1, wherein the concentration of the coprecipitant is 0.5 to 100 μg/ml. 8. A method for detecting nucleic acids during treatment to prepare refined nucleic acid from a biological sample, comprising:(a) contacting a biological sample containing nucleic acids with a coprecipitant at a time during a treatment to prepare refined said nucleic acids prior to or during step (b), said coprecipitant comprising at least one compound selected from the group consisting of starch azure, amylopectin azure and amylose azure, soluble starch, corn starch, potato starch, potato soluble starch, wheat starch, corn amylopectin, potato amylopectin, amylopectin anthranilate, insoluble corn amylopectin, soluble potato amylopectin, corn amylose, and potato amylose,(b) precipitating said biological sample and coprecipitant by adding alcohol, and(c) visibly detecting a blue or white precipitate to indicate the presence of said nucleic acid and coprecipitant. 9. A method according to claim 8, wherein said at least one coprecipitant is selected from the group consisting of starch azure, amylopectin azure and amylose azure, and said precipitate in step (c), is blue. 10. A method according to claim 8, wherein said alcohol is isopropyl alcohol or ethanol. 11. A method according to claim 8, wherein the nucleic acids are HCV-RNA. 12. A method according to claim 8, wherein the concentration of said coprecipitant is 0.5 to 100 μg/ml. 13. A method according to claim 8, wherein said precipitate is facilitated by centrifuging. 14. A method according to claim 8, wherein said treatment to prepare refined nucleic acids, comprises prior to step (b) performing the steps of (i) lysing, and (ii) deproteinizing said biological sample. 15. The method according to claim 14, wh erein the step of deproteinizing comprises the steps: phase separation and extraction by phenol, solubilization of protein by a chaotropic agent, formation of nucleic acid complex by a cationic surfactant, and capture of nucleic acids by a glass filter or capture of nucleic acids by magnetic beads. 16. A method according to claim 14, further comprising after performing step (b), washing, and further refining said nucleic acid. 17. A method according to claim 14, wherein said at least one coprecipitant is selected from the group consisting of starch azure, amylopectin azure and amylose azure, and said precipitate in step (b) is blue. 18. A method according to claim 8, wherein said treatment to prepare refined nucleic acid comprises, prior to step (b)(i) eluting nucleic acids from biological sample;(ii) mixing an aqueous liquid, a non-hydrophilic organic liquid having a high specific gravity, a thixotropic thickening agent, and the eluted biological sample, and(iii) centrifuging and separating an upper phase containing nucleic acids by forming a non-flowable agglutinated phase in a boundary interface between said upper phase and a lower phase. 19. A method according to claim 18, wherein said at least one coprecipitant is selected from the group consisting of starch azure, amylopectin azure and amylose azure, and said precipitate in step (c), is blue. 20. A method according to claim 18, wherein said precipitate is facilitated by centrifuging.